#

---

{{< rawhtml >}}

<h1 align="center">Members of the iCFree consortium</h1>

{{< /rawhtml >}}

---


{{< rawhtml >}}

<br>

<center> <a href="https://www.micalis.fr/micalis_eng/Micalis-Institute"><img src="/img/micalis.png" width="300" height="125" /></a></center>

<br>

<p align="justify">

The <b>MICALIS institute (INRAE, AgroParisTech, Univ. of Paris Saclay)</b> has several years of experience and published records in optimizing prokaryotic cell-free systems with machine learning for biomanufacturing and developing biosensors.

</p>
{{< /rawhtml >}}

---

{{< rawhtml >}}
<center><a href="https://www.i2bc.paris-saclay.fr/"><img src="/img/i2bc.png" width="300" height="300" /></a></center>

<br>

<p align="justify">

The <b>I2BC institute (CEA, CNRS, Univ. of Paris Saclay)</b> brings the know-how in the recombinant production of peptides and proteins and in the biological incorporation of ncAAs into peptides.

</p>

{{< /rawhtml >}}

---

{{< rawhtml >}}
<center><a href="http://carmen.univ-lyon1.fr/"><img src="/img/carmen.png" width="300" height="200"/></a> </center>

<br>

<p align="justify">

The <b>CarMeN institute (Inserm, Univ. Claude Bernard Lyon 1)</b> has a strong background in in vitro eukaryotic transcription and translation mechanisms.

</p>

{{< /rawhtml >}}

---

{{< rawhtml >}}
<center><a href="https://www.synthelis.com/"><img src="/img/synthelis.png" width="400" height="200"/></a></center>

<br>

<p align="justify">

<b>Synthelis</b> is a biotech that offers more than 10 years of expertise in protein production using cell-free systems. To date, the team has successfully produced over 230 difficult-to-express proteins using its cell-free technology.

</p>

{{< /rawhtml >}}